Catalyst Biosciences Inc (CBIO)

0.1926 -0.01 (-4.94%) USD  |  NASDAQ  |  Mar 20, 16:00
0.1926 0.00 (0.00%) After-Hours: 18:26
More

Catalyst Biosciences News

News

Headline
Wire
Time (ET)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, CBIO, AQUA, OSH
PR Newswire
03/16 11:45
SHAREHOLDER ALERT: Weiss Law Reminds SHBI, CBIO, TA, and CSII Shareholders About Its Ongoing Investigations
PR Newswire
03/15 15:35
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLVF, TCFC, CBIO, MAXR
Globe Newswire
03/12 12:15
CATALYST BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Catalyst Biosciences, Inc. - CBIO
PR Newswire
03/09 21:21
INVESTIGATION ALERT: Halper Sadeh LLC Investigates OSH, ANGN, CBIO, ALR
PR Newswire
03/07 11:50
SHAREHOLDER ALERT: Weiss Law Reminds DCP, MLVF, SHBI, and CBIO Shareholders About Its Ongoing Investigations
PR Newswire
03/07 02:41
SHAREHOLDER ALERT: Weiss Law Reminds DCP, MLVF, SHBI, and CBIO Shareholders About Its Ongoing Investigations
PR Newswire
02/28 21:00
Thinking about buying stock in Troika Media, Bioventus, Catalyst Biosciences, Norwegian Cruise Line, or Luminar Technologies?
PR Newswire
02/28 10:59
Wider-Than-Expected Trade in Goods Deficit Kicks Off Tuesday's Data Dump, Stifling US Equity Futures
MT Newswires
02/28 08:56
Catalyst Biosciences Provides Corporate Update
Globe Newswire
02/28 08:00
Top Premarket Gainers
MT Newswires
02/28 07:52
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AJRD, MPB, CBIO, DCT
PR Newswire
02/23 12:05
SHAREHOLDER ALERT: Weiss Law Reminds CBIO, AJRD, SAL, MPB Shareholders About Its Ongoing Investigations
PR Newswire
02/23 08:00
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TA, CBIO, MPB
PR Newswire
02/17 11:27
SHAREHOLDER ALERT: Weiss Law Reminds GPN, SHBI, CBIO, and AJRD Shareholders About Its Ongoing Investigations
PR Newswire
02/16 19:51
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, BLI, ISO, CBIO
Globe Newswire
02/11 08:57
SHAREHOLDER ALERT: Weiss Law Reminds SHBI, CBIO, AJRD, and SAL Shareholders About Its Ongoing Investigations
PR Newswire
02/10 15:47
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBO, AJRD, CBIO, STAR
Globe Newswire
02/03 07:27
SHAREHOLDER ALERT: Weiss Law Reminds SHBI, CBIO, AJRD, and SAL Shareholders About Its Ongoing Investigations
PR Newswire
02/02 08:00
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates QUMU, MPB, CBIO
PR Newswire
01/26 13:13
SHAREHOLDER ALERT: Weiss Law Reminds CBIO, AJRD, SAL, and SHBI Shareholders About Its Ongoing Investigations
PR Newswire
01/26 08:00
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, HZN, CLXT, VLTA
PR Newswire
01/19 10:50
SHAREHOLDER ALERT: Weiss Law Reminds APEN, HZN, CBIO, and AJRD Shareholders About Its Ongoing Investigations
PR Newswire
01/18 17:00
Top Premarket Decliners
MT Newswires
01/13 07:46
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, AJRD, QUMU, CBIO
PR Newswire
01/11 11:11
SHAREHOLDER ALERT: Weiss Law Reminds HZN, CBIO, AJRD, and SAL Shareholders About Its Ongoing Investigations
PR Newswire
01/10 20:45
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPNT, CBIO
Globe Newswire
01/08 08:47
SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – HZN, CBIO, SAFE, IAA
Globe Newswire
01/06 20:00
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Catalyst Biosciences, Inc. - CBIO
PR Newswire
01/04 21:55
SHAREHOLDER ALERT: Weiss Law Investigates Catalyst Biosciences, Inc.
PR Newswire
01/04 18:31
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZN, BLI, ISO, CBIO
PR Newswire
01/03 11:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, BLI, ISO, CBIO
Globe Newswire
12/29 09:34
Lifshitz Law PLLC Announces Investigations of CBIO, ISO, BLI, and APEN
Globe Newswire
12/28 19:11
Sector Update: Health Care Edging Higher at Tuesday Close
MT Newswires
12/27 16:15
Sector Update: Health Care Stocks Still Struggling for Direction
MT Newswires
12/27 14:21
Sector Update: Health Care
MT Newswires
12/27 13:37
Catalyst Biosciences Acquires F351, Controlling Interest in Continent From GNI Group
MT Newswires
12/27 09:02
Catalyst Biosciences closes first steps in reverse merger plan
SA Breaking News
12/27 08:46
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
Globe Newswire
12/27 07:00
Top Premarket Decliners
MT Newswires
09/21 08:08
Catalyst Biosciences, Inc. Announces September 21, 2022 as the Ex-Dividend Date for Special Cash Dividend of $1.43 per share
Globe Newswire
09/01 16:05
--Catalyst Biosciences to Pay Special Cash Dividend of $1.43 a Share on Sept. 20 to Holders as of Sept. 6
MT Newswires
08/25 10:05
Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share
Globe Newswire
08/25 08:00
Catalyst Biosciences Says JDS1 Litigation Dismissed
MT Newswires
08/19 08:35
Catalyst Biosciences, Inc. Announces Dismissal of JDS1 Litigation
Globe Newswire
08/19 08:00
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Catalyst Stockholders Vote “FOR” All of the Company’s Nominees on the WHITE Proxy Card
Globe Newswire
08/03 08:00
Catalyst Biosciences Announces Support from Largest Single Stockholder
Globe Newswire
08/01 07:30
Catalyst Biosciences Gets Favorable Court Ruling in Shareholder JDS1's Motion for Expedited Proceedings Regarding Disclosures
MT Newswires
07/06 11:55
Catalyst Biosciences Comments on Favorable Delaware Court of Chancery Ruling
Globe Newswire
07/06 08:00
AGEN, SMFR and NCTY among pre market gainers
SA Breaking News
06/29 08:43
Catalyst Biosciences plans to distribute $65M cash to stockholders
SA Breaking News
06/29 08:18
Catalyst Biosciences Announces Plan to Distribute Cash to Stockholders
Globe Newswire
06/29 08:00
Thinking about buying stock in Revlon, Mereo BioPharma, Precision BioSciences, Catalyst Biosciences, or La-Z-Boy?
PR Newswire
06/22 08:30
Thinking about buying stock in Covetrus, Marathon Oil, BigBear.ai, Catalyst Biosciences, or Pinterest?
PR Newswire
05/25 10:55
Thinking about buying stock in Snap, General Electric, Catalyst Biosciences, Genocea Biosciences, or Redbox Entertainment?
PR Newswire
05/24 10:56
Thinking about buying stock in Catalyst Biosciences, Nordic American Tanker, Borqs Technologies, Chimerix, or AgriFORCE Growing Systems?
PR Newswire
05/23 10:59
Catalyst Biosciences Stock Surges After Vertex Pharmaceuticals Buys Catalyst's Complement Portfolio for $60 Million
MT Newswires
05/23 10:31
Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results
Globe Newswire
05/09 08:30
Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
03/31 08:00
Catalyst Biosciences Regains Rights to Dry AMD Treatment From Biogen
MT Newswires
03/16 12:12
Sector Update: Health Care Stocks Fading Ahead of Thursday Close
MT Newswires
02/17 15:22
Sector Update: Health Care Stocks Floundering This Afternoon
MT Newswires
02/17 13:10
Catalyst Biosciences Retains Perella Weinberg as Financial Adviser Amid Efforts to Evaluate Strategic Alternatives
MT Newswires
02/17 11:11
Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic Alternatives
Globe Newswire
02/17 08:00
Thinking about buying stock in Aptorum Group, Ford Motor, Nokia, Catalyst Biosciences, or General Electric?
PR Newswire
01/25 10:45
Catalyst Biosciences Secures Rare Pediatric Disease Designation for Immune Defect Drug
MT Newswires
01/25 10:10
Catalyst Bio's stock jumps 21% after securing Rare Pediatric Disease tag for CB 4332
SA Breaking News
01/25 08:22
Catalyst Biosciences Receives Rare Pediatric Disease Designation for CB 4332 for the Treatment of CFI Deficiency
Globe Newswire
01/25 08:00
Catalyst granted FDA’s orphan drug designation for hemophilia drug
SA Breaking News
12/17 10:51
Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
Globe Newswire
11/22 08:00
--Piper Sandler Adjusts Price Target on Catalyst Biosciences to $4 From $16, Reiterates Overweight Rating
MT Newswires
11/15 09:53
--Raymond James Downgrades Catalyst Biosciences to Market Perform From Outperform
MT Newswires
11/15 05:45
--JonesTrading Downgrades Catalyst Biosciences to Hold From Buy
MT Newswires
11/15 05:44
Sector Update: Health Care Stocks Gaining Strength Late in Friday Trade
MT Newswires
11/12 15:53
Top Midday Decliners
MT Newswires
11/12 13:52
Sector Update: Health Care Stocks Posting Slim Gains This Afternoon
MT Newswires
11/12 13:38
Wall Street Sees Higher Open as J&J Split Buoys Sentiment
MT Newswires
11/12 09:15
Catalyst Biosciences to Stop Hemophilia Drug Candidate Development; Loss Widens in Q3 as Revenue Rises
MT Newswires
11/12 08:36
Top Premarket Decliners
MT Newswires
11/12 08:07
Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences
Globe Newswire
10/29 08:00
Catalyst Biosciences CFO Resigns; Interim Successor Named
MT Newswires
10/13 16:13
Catalyst Biosciences Announces Chief Financial Officer Transition
Globe Newswire
10/13 16:05
FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency
Globe Newswire
09/28 16:01
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
Globe Newswire
09/24 08:00
CEI, CEMI and CBIO among pre market gainers
SA Breaking News
09/10 08:16
Apellis' mixed eye-drug data turns out to be 'positive' for Iveric Bio
SA Breaking News
09/10 07:09
Catalyst Biosciences Announces Oral and Poster Presentations at the International Conference on Complement Therapeutics
Globe Newswire
09/09 08:00
Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors
Globe Newswire
09/08 08:00
Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
08/05 08:00
Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies
Globe Newswire
07/22 08:00
Seeking Alpha Catalyst Watch
SA Breaking News
07/16 15:00
Catalyst Biosciences Elevates Grant Blouse to Chief Scientific Officer
MT Newswires
07/15 17:01
Catalyst Biosciences Announces Key Leadership Changes in its Ongoing Transition to an Integrated Protease Medicines Company
Globe Newswire
07/14 08:00
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
Globe Newswire
07/06 08:00
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency
Globe Newswire
06/28 08:00
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
Globe Newswire
06/10 08:00
Catalyst Biosciences Doses First Patient in Phase 1/2 Study of Drug Candidate for Bleeding Disorders
MT Newswires
05/18 08:48
Catalyst starts dosing in early-stage MarzAA trial
SA Breaking News
05/18 08:20
Catalyst Biosciences Announces First Patient Dosed in Marzeptacog Alfa (Activated) Phase 1/2 Study in Factor VII Deficiency, Glanzmann Thrombasthenia and Hemophilia A treated with Hemlibra
Globe Newswire
05/18 08:00
Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit
Globe Newswire
05/13 08:00
Catalyst Biosciences EPS misses by $0.12, beats on revenue
SA Breaking News
05/06 08:47
Catalyst Biosciences Reports First Quarter 2021 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
05/06 08:00
Catalyst Biosciences Doses First Patient in Phase 3 Study of Potential Hemophilia Drug Candidate
MT Newswires
05/05 11:07
Catalyst Biosciences Announces First Patient Dosed in Pivotal Phase 3 Registration Study of SQ MarzAA in Individuals with Hemophilia A or B with Inhibitors
Globe Newswire
05/05 08:00
Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene Therapy Data in Blood, the Journal of the American Society of Hematology
Globe Newswire
04/19 08:00
Catalyst Biosciences Expands its Protease Medicines Patent Portfolio of Complement Factor 3 Degraders
Globe Newswire
04/12 08:00
Catalyst Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference
Globe Newswire
04/07 16:05
Thinking about buying stock in Ion Geophysical, OncoCyte, electroCore, CytomX Therapeutics, or Catalyst Biosciences?
PR Newswire
03/23 09:31
Catalyst Biosciences Files Shelf for Up to $150 Million in Securities
MT Newswires
03/05 03:13
Catalyst Biosciences EPS misses by $0.26, beats on revenue
SA Breaking News
03/04 09:04
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
03/04 08:00
Catalyst Biosciences to Present at the 42nd Annual Raymond James Institutional Investors Conference
Globe Newswire
02/18 08:00
Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock
Globe Newswire
02/11 16:01
--Analyst Actions: Piper Sandler Starts Catalyst Biosciences at Overweight With $15 Price Target
MT Newswires
02/10 07:57
--Analyst Actions: Raymond James Adjusts Price Target on Catalyst Biosciences to $18 From $20, Keeps Outperform Rating
MT Newswires
02/04 07:29
Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress
Globe Newswire
02/03 08:00
Catalyst Biosciences Completes $50 Million Stock Sale
MT Newswires
01/29 16:14
Catalyst Biosciences announces closing of $50M capital raise
SA Breaking News
01/29 16:06
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
Globe Newswire
01/29 16:01
Catalyst Biosciences under pressure on pricing 8.7M equity offering
SA Breaking News
01/27 08:27
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Globe Newswire
01/27 08:00
Catalyst Biosciences to Sell Shares in Public Offering -- Shares Slump 5.5% After Hours
MT Newswires
01/26 16:24
Catalyst Biosciences down 5% after launching underwritten public offering
SA Breaking News
01/26 16:19
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
Globe Newswire
01/26 16:04
Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress
Globe Newswire
01/20 08:00
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
Globe Newswire
01/15 08:00
Seeking Alpha Catalyst Watch
SA Breaking News
12/11 15:30
Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference
Globe Newswire
12/07 08:00
Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs
Globe Newswire
12/03 16:01
Catalyst Bio Factor VIIa variant Fast Track'd in U.S. for hemophilia
SA Breaking News
12/02 10:15
Catalyst Biosciences' MarzAA fast track'd for episodic bleeding in hemophilia patients
SA Breaking News
12/02 09:44
Catalyst Biosciences Receives FDA Fast Track Designation for a Potential Treatment Against Bleeding Marzeptacog Alfa
MT Newswires
12/02 08:56
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors
Globe Newswire
12/02 08:00
Catalyst Biosciences to Present at 32nd Annual Piper Sandler Virtual Healthcare Conference
Globe Newswire
11/24 16:01
Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference
Globe Newswire
11/05 09:00
Catalyst Biosciences EPS beats by $0.06
SA Breaking News
11/05 08:20
Catalyst Biosciences Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
11/05 08:00
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
Globe Newswire
11/03 08:00
RESI, BSTC, WWR and NNDM among midday movers
SA Breaking News
10/19 12:44
Catalyst Biosciences Secures Patent for Engineered Proteases Portfolio Including Dry Age-Related Macular Degeneration Candidate
MT Newswires
10/14 10:58
Catalyst Bio secures US patent for engineered proteases
SA Breaking News
10/14 08:36
Catalyst Biosciences Receives US Patent for its Anti-Complement Factor 3 Portfolio of Engineered Proteases
Globe Newswire
10/14 08:00
Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit
Globe Newswire
09/25 08:00
Catalyst Biosciences to Participate in Two Upcoming Investor Conferences
Globe Newswire
09/10 08:00
Hemophilia A players in the green on BioMarin gene therapy delay in U.S.
SA Breaking News
08/19 13:24
Catalyst Biosciences Reports Second Quarter 2020 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
08/06 08:00
Catalyst Biosciences Presents Data at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress
Globe Newswire
07/13 08:00
Catalyst Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
07/01 16:48
Catalyst Biosciences joins Russell 2000 index
SA Breaking News
06/29 13:53
Catalyst Biosciences Added to Russell 2000 Index
Globe Newswire
06/29 08:00
Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis
Globe Newswire
06/29 08:00
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
Globe Newswire
06/22 16:05
Catalyst Biosciences Appoints Charles Democko, Senior Vice President, Regulatory Affairs
Globe Newswire
06/22 08:00
Catalyst Biosciences Presents Preclinical FIX Gene Therapy Data in an Oral Presentation at the World Federation of Hemophilia Virtual Summit 2020
Globe Newswire
06/19 11:45
Catalyst Biosciences Prices Offering of 4.6 Million Shares at Discount; Shares Fall Pre-Bell
MT Newswires
06/18 09:27
Catalyst Bio in red after pricing stock offering
SA Breaking News
06/18 09:22
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Globe Newswire
06/18 09:00
SSL, CCL among premarket losers
SA Breaking News
06/18 08:51
Catalyst Bio initiates equity offering
SA Breaking News
06/17 16:10
Catalyst Biosciences to Sell Shares in Public Offering
MT Newswires
06/17 16:08
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
Globe Newswire
06/17 16:01
Catalyst Biosciences Reports Positive Data From Trial of DalcA to Treat Hemophilia B; Shares Rise 4%
MT Newswires
06/15 12:00
Catalyst Biosciences Names Clinton Musil CFO
MT Newswires
06/15 08:30
New finance chief for Catalyst Biosciences
SA Breaking News
06/15 08:30
Catalyst Biosciences Appoints Clinton Musil as Chief Financial Officer
Globe Newswire
06/15 08:00
Catalyst Biosciences Presents Positive Final Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) at the World Federation of Hemophilia Virtual Summit 2020
Globe Newswire
06/15 07:00
Catalyst Biosciences Present at the Raymond James Human Health Innovation Conference
Globe Newswire
06/12 08:00
Catalyst Biosciences Completes MarzAA Pharmacokinetic & Pharmacodynamic Study
Globe Newswire
06/10 08:00
Catalyst Biosciences Announces Oral and Poster Presentations at the World Federation of Hemophilia Virtual Summit 2020
Globe Newswire
06/08 08:00
--Analyst Actions: Raymond James Initiates Coverage on Catalyst Biosciences With Outperform Rating, $20 Price Target
MT Newswires
05/21 12:40
Catalyst Biosciences reports Q1 results
SA Breaking News
05/11 08:10
Catalyst Biosciences Reports First Quarter 2020 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
05/11 08:00
Catalyst Biosciences Receives Patent in the European Union for Its Factor IX Portfolio
Globe Newswire
04/28 08:00
Catalyst Biosciences Completes Phase 2b Trial Dosing of Dalcinonacog Alfa in Hemophilia Patients
MT Newswires
04/21 15:50
Catalyst completes successful study of DalcA in hemophilia B
SA Breaking News
04/21 08:29
Catalyst Biosciences Completes Phase 2b Trial of Subcutaneous Factor IX Dalcinonacog Alfa (DalcA)
Globe Newswire
04/21 08:00
Catalyst Biosciences Preps for Late-Stage Trial for Hemophilia Drug MarzAA After Guidance from Regulators, Stock Rises
MT Newswires
04/06 14:56
Catalyst Bio on go with late-stage study of MarzAA; shares up 9%
SA Breaking News
04/06 09:42
Catalyst Biosciences Announces Pivotal Phase 3 Study Design for MarzAA in Individuals with Hemophilia A or B with Inhibitors
Globe Newswire
04/06 08:00
FDA OKs new hemophilia treatment
SA Breaking News
04/01 13:51
Catalyst Biosciences to Present at the Cowen Healthcare Conference
Globe Newswire
02/24 08:00
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2019 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
02/20 16:05
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
Globe Newswire
02/18 16:05
Close Update: Stocks Slip Thursday as Coronavirus Worries Return
MT Newswires
02/13 16:28
Update: Catalyst Biosciences Plummets 20% After Pricing $30 Million Share Offering
MT Newswires
02/13 15:57
Midday Report: US Stocks Struggle to Find Direction After WHO Downplays Jump in New Coronavirus Infections Data From China; Gold Gains With Yen
MT Newswires
02/13 13:42
INO, RDFN, SPWR and NUS among midday movers
SA Breaking News
02/13 12:41
Catalyst Biosciences Prices $30 Million Share Offering
MT Newswires
02/13 11:41
Inovio Pharmaceuticals among healthcare gainers; XBiotech and Catalyst Biosciences among losers
SA Breaking News
02/13 11:02
Catalyst Bio down 16% after pricing equity offering
SA Breaking News
02/13 09:35
NTAP, AEG among premarket losers
SA Breaking News
02/13 09:17
Catalyst Biosciences Announces Pricing of Public Offering of Common Stock
Globe Newswire
02/13 09:15
Catalyst Bio down 14% premarket on equity offering
SA Breaking News
02/13 08:45
MT Newswires After-Hours News Movers
MT Newswires
02/12 17:57
Catalyst Biosciences Plans to Sell Shares in Underwritten Public Offering
MT Newswires
02/12 17:03
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
Globe Newswire
02/12 16:15
Catalyst Biosciences Jumps 9% After Phase 2b Trial Data Show 'Positive' Results From Hemophilia B Treatment
MT Newswires
02/07 14:30
Catalyst Biosciences up 13% premarket on positive FIX data
SA Breaking News
02/07 07:07
Catalyst Biosciences Presents Positive Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) and Marzeptacog alfa (activated) (MarzAA) Programs at the 13th Annual EAHAD Congress
Globe Newswire
02/07 03:30
Key events next week - healthcare
SA Breaking News
01/31 10:30
Catalyst Bio up 6% on positive DalcA data
SA Breaking News
01/30 10:48
Catalyst Biosciences Announces Oral and Poster Presentations at the 13th Annual EAHAD Congress
Globe Newswire
01/27 08:00
Catalyst Biosciences Announces Addition of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to Board of Directors
Globe Newswire
01/17 08:00
RAD, INO, MDR and ASNA among midday movers
SA Breaking News
12/19 12:43
Catalyst Biosciences Shares Up 40% on License, Collaboration Agreement with Biogen for Dry AMD Treatment
MT Newswires
12/19 12:39
Healthcare - Top 5 Gainers / Losers
SA Breaking News
12/19 11:01
Wall Street in Holding Pattern after US House Votes to Impeach Trump
MT Newswires
12/19 09:21
CAG, RAD among premarket gainers
SA Breaking News
12/19 09:20
Catalyst Bio up 37% premarket on Biogen deal in dry AMD
SA Breaking News
12/19 08:29
Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
Globe Newswire
12/19 08:00
Catalyst Biosciences Presents Two Posters on MarzAA at the 61st Annual American Society of Hematology Conference
Globe Newswire
12/09 08:00
Catalyst Biosciences to Present at the Stifel Healthcare Conference
Globe Newswire
11/12 08:00
Catalyst Biosciences Reports Third Quarter 2019 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
11/07 08:00
Catalyst Biosciences Announces Poster Presentations at the 61st Annual American Society of Hematology Conference
Globe Newswire
11/06 08:00
Microcaps mostly among midday movers
SA Breaking News
10/04 12:51
Catalyst Biosciences Says Trial for Blood Disorder Drug Has Completed Dosing, Washout for Two Subjects; Shares Jump 25%
MT Newswires
10/03 15:48
Catalyst Bio reports positive trial update on blood disorder drug
SA Breaking News
10/03 15:10
Microcaps mostly among midday movers
SA Breaking News
10/03 12:55
Healthcare - Top 5 Gainers / Losers
SA Breaking News
10/03 11:01
Catalyst Biosciences Provides DalcA Phase 2b Trial Update
Globe Newswire
10/03 08:00
AIMT, AYI, NIO and TSG among midday movers
SA Breaking News
10/02 12:43
22NW: Catalyst Biosciences Needs Change Now
PR Newswire
10/02 09:00
Catalyst Biosciences Shareholder Pushes for Company Sale
MT Newswires
09/27 15:45
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
Globe Newswire
09/26 08:00
Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference
Globe Newswire
09/05 08:00
Catalyst Biosciences CFO Payne Stepping Down
MT Newswires
08/29 17:00
Catalyst Biosciences Announces Transition of Chief Financial Officer
Globe Newswire
08/29 16:55
--Analyst Actions: Chardan Cuts Price Target on Catalyst Biosciences to $25 From $35, Maintains Buy Rating
MT Newswires
08/26 07:16
Catalyst Biosciences to Present at the 2019 Hemophilia Drug Development Summit
Globe Newswire
08/16 08:00
Catalyst Biosciences to Host Key Opinion Leader Meeting on Next-Generation Subcutaneous Factor VIIa Marzeptacog Alfa (Activated) in Patients with Bleeding Disorders on August 15
Globe Newswire
08/08 08:00
Catalyst Biosciences Shares Rise More Than 5% on Smaller Q2 Loss Than Consensus
MT Newswires
08/01 15:09
Catalyst Biosciences EPS beats by $0.05
SA Breaking News
08/01 08:22
Catalyst Biosciences Reports Second Quarter 2019 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
08/01 08:00
Microcaps mostly among midday movers
SA Breaking News
07/08 12:32
Wall Street Sees Lower Open After Strong US Jobs Data
MT Newswires
07/08 08:59
US Futures Fall After Strong US Jobs Data
MT Newswires
07/08 08:11
Catalyst Bio's MarzAA successful in mid-stage hemophilia study
SA Breaking News
07/08 07:09
Catalyst Biosciences Soars Nearly 30% Pre-Bell as MarzAA Trial To Treat Hemophilia Meets Endpoints
MT Newswires
07/08 05:42
Catalyst Biosciences Meets the Primary Endpoint of Reduction in Annualized Bleeding Rate in the Phase 2 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Patients with Hemophilia A or B with Inhibitors
Globe Newswire
07/08 05:00
Healthcare - Top 5 Gainers / Losers
SA Breaking News
07/05 11:01
Catalyst Biosciences Announces Oral and Poster Presentations at the International Society on Thrombosis and Haemostasis
Globe Newswire
07/01 08:00
Catalyst Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
Globe Newswire
05/28 08:00
Catalyst Biosciences misses by $0.16
SA Breaking News
05/02 08:41
Catalyst Biosciences Reports First Quarter 2019 Operating & Financial Results and Provides a Corporate Update
Globe Newswire
05/02 08:00
Catalyst Biosciences & Mosaic Biosciences Present Preclinical Data on Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
Globe Newswire
04/29 08:05
Key events next week - healthcare (Part 1)
SA Breaking News
04/26 10:52
New Research: Key Drivers of Growth for CBRE Group, Brookfield Asset Management, Zebra Technologies, Trex, Catalyst Biosciences, and Albireo Pharma — Factors of Influence, Major Initiatives and Sustained Production
Globe Newswire
04/15 08:10
Catalyst Biosciences to Present at The Needham & Company 18th Annual Healthcare Conference
Globe Newswire
04/03 08:00
Catalyst Biosciences Commences Phase 2b Trial for Hemophilia B Treatment
MT Newswires
04/02 10:09
Catalyst Biosciences Initiates a Phase 2b Trial of Dalcinonacog Alfa for the Treatment of Hemophilia B
Globe Newswire
04/02 08:00